Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Neurosci ; 22(23): 10217-31, 2002 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-12451123

RESUMEN

Despite the importance of myelinating Schwann cells in health and disease, little is known about the genetic mechanisms underlying their development. The POU domain transcription factor pou3f1 (Tst-1, SCIP, Oct-6) is required for the normal differentiation of myelinating Schwann cells, but its precise role requires identification of the genes that it regulates. Here we report the isolation of six genes whose expression is reduced in the absence of pou3f1. Only one of these genes, the fatty acid transport protein P2, was known previously to be expressed in Schwann cells. The LIM domain proteins cysteine-rich protein-1 (CRP1) and CRP2 are expressed in sciatic nerve and induced by forskolin in cultured Schwann cells, but only CRP2 requires pou3f1 for normal expression. pou3f1 appears to require the claw paw gene product for activation of at least some of its downstream effector genes. Expression of the novel Schwann cell genes after nerve injury suggests that they are myelin related. One of the genes, tramdorin1, encodes a novel amino acid transport protein that is localized to paranodes and incisures. Our results suggest that pou3f1 functions to activate gene expression in the differentiation of myelinating Schwann cells.


Asunto(s)
Proteínas Aviares , Regulación hacia Abajo/fisiología , Perfilación de la Expresión Génica , Nervio Ciático/metabolismo , Neuropatía Ciática/metabolismo , Factores de Transcripción/deficiencia , Proteínas Adaptadoras Transductoras de Señales , Sistemas de Transporte de Aminoácidos/fisiología , Animales , Proteína beta Potenciadora de Unión a CCAAT/metabolismo , Proteínas Portadoras/metabolismo , Diferenciación Celular/fisiología , Membrana Celular/metabolismo , Células Cultivadas , Colforsina/farmacología , Citoesqueleto/metabolismo , Modelos Animales de Enfermedad , Regulación hacia Abajo/efectos de los fármacos , Proteínas con Dominio LIM , Ratones , Ratones Mutantes , Vaina de Mielina/metabolismo , Factor 6 de Transcripción de Unión a Octámeros , Estructura Terciaria de Proteína/fisiología , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Células de Schwann/citología , Células de Schwann/efectos de los fármacos , Células de Schwann/metabolismo , Nervio Ciático/lesiones , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
2.
Mol Cell Neurosci ; 19(3): 307-19, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11906205

RESUMEN

We have examined the effects of transforming growth factor beta1 (TGFbeta1) on gene expression in cultured rat Schwann cells (SCs). TGFbeta1 decreased the steady-state mRNA levels of several genes that are expressed by myelinating SCs but had varied effects on the mRNA levels of NCAM, L1, GAP-43, and p75-genes that are expressed by denervated and nonmyelinating SCs. TGFbeta1 antagonized the effects of forskolin on the mRNA levels of the transcription factors Oct-6/tst-1/SCIP and Krox20. Transcriptional run-off analysis demonstrated that the effects of TGFbeta1 on gene expression occur at least in part at the level of transcription. Thus, TGFbeta1 suppresses the expression of genes that characterize the different phenotypes of SCs, and these changes occur at least in part at a transcriptional level.


Asunto(s)
Células de Schwann/efectos de los fármacos , Células de Schwann/fisiología , Transcripción Genética/efectos de los fármacos , Factor de Crecimiento Transformador beta/farmacología , Animales , Células Cultivadas , Colforsina/farmacología , Medios de Cultivo/farmacología , Expresión Génica/efectos de los fármacos , Masculino , Vaina de Mielina/fisiología , Factor 6 de Transcripción de Unión a Octámeros , Fenotipo , Proteínas Proto-Oncogénicas c-jun/genética , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Células de Schwann/citología , Nervio Ciático/citología , Factores de Transcripción/genética , Factor de Crecimiento Transformador beta1
3.
Neurobiol Dis ; 11(1): 43-52, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12460545

RESUMEN

Mutations in GJB1, the gene encoding the gap junction protein connexin32 (Cx32), cause X-linked Charcot-Marie-Tooth disease (CMTX). We compared the localization of CMTX mutants that affect different domains of Cx32, by expressing them in HeLa cells. Mutants were localized to the endoplasmic reticulum (M34K, N205I, and Y211x), in the Golgi apparatus without reaching the cell membrane (M34T, V38M, A40V, R75Q, R75P, R75W, and C217x), in the Golgi apparatus but also forming rare small gap junction-like plaques (M34I, M34V, and V37M), or mainly on the cell membrane, forming gap junction-like plaques (V35M, I213V, R219C, R219H, R220G, R230C, R230L, R238H, L239I, and S281x). Selected mutants expressed in cultured rat Schwann cells showed localization similar to that in HeLa cells. Thus, many CMTX mutants have trafficking abnormalities, whereas the carboxy-terminus mutants reach the cell membrane and probably cause disease through other mechanisms.


Asunto(s)
Enfermedad de Charcot-Marie-Tooth/metabolismo , Conexinas/genética , Neuronas/metabolismo , Cromosoma X , Secuencia de Aminoácidos , Animales , Enfermedad de Charcot-Marie-Tooth/genética , Conexinas/química , Uniones Comunicantes/metabolismo , Células HeLa , Humanos , Datos de Secuencia Molecular , Mutación Missense , Neuronas/citología , Estructura Terciaria de Proteína , Transporte de Proteínas/fisiología , Ratas , Células de Schwann/citología , Células de Schwann/metabolismo , Nervio Ciático/citología , Proteína beta1 de Unión Comunicante
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA